Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) are tax-advantaged accounts that allow Americans to set aside pre-tax dollars for qualified medical expenses. HSAs are available to individuals enrolled in high-deductible health plans (HDHPs), while FSAs are employer-sponsored accounts that can be used with any health plan. Under current law, both accounts are funded through voluntary employee salary reductions or employer contributions, with no direct government subsidy. The prediction market question asks whether a bill that directly channels government funds into these accounts will become law before January 1, 2027, which would represent a major shift in how healthcare savings are incentivized in the United States. Interest in direct government funding for HSAs and FSAs has grown in recent years as healthcare costs have risen and policymakers from both parties have looked for ways to increase healthcare affordability and consumer choice. Proponents argue that direct contributions would help lower-income individuals who cannot afford to save on their own, while critics worry about the fiscal cost and the potential to undermine the employer-based insurance system. Several bills introduced in the 118th Congress (2023-2024) included provisions to fund HSAs or FSAs, but none have advanced to final passage. The question of whether such legislation will become law before 2027 is a test of political will amid ongoing debates over healthcare reform. The market's resolution criteria are specific: a bill must pass both chambers of Congress (or be a joint resolution), be signed by the President or become law via veto override, and must directly fund HSAs or FSAs. This means that legislation like the HSA Expansion Act or the Bipartisan HSA Improvement Act, which expand eligibility or contribution limits but do not provide direct funding, would not count. Only bills that explicitly appropriate government funds into these accounts, such as through a matching contribution program or a direct deposit for certain taxpayers, would meet the criteria. As of early 2025, no such bill has been enacted, but the 119th Congress and the upcoming budget reconciliation process could change that. For traders and observers, this market captures a specific policy outcome that is both measurable and time-bound. The outcome depends on a complex mix of legislative dynamics, fiscal constraints, and political priorities. Understanding the current landscape, the key players, and the historical precedents is essential for evaluating the likelihood of this unusual policy becoming law.

Historical Context

HSAs were established by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, signed by President George W. Bush, and first became available in January 2004. They were designed as a replacement for the older Medical Savings Accounts (MSAs) and were intended to encourage consumers to save for healthcare costs while enrolled in high-deductible plans. FSAs have existed since the Revenue Act of 1978, which allowed employees to set aside pre-tax dollars for medical expenses, though their rules have been tightened over the years to prevent abuse. Neither program has ever received direct government funding; they are tax expenditures that reduce federal revenue by an estimated $18 billion for HSAs and $4 billion for FSAs over the next decade, according to the Joint Committee on Taxation. Throughout the 2010s, there were occasional proposals to add a government contribution to HSAs, often as part of broader healthcare reform plans. For example, the 2017 Graham-Cassidy bill, which would have replaced the Affordable Care Act, included a provision for state-based funding that could have been used for HSAs, but it did not pass. More recently, the 2020 CARES Act, passed during the COVID-19 pandemic, expanded HSA eligibility to cover telehealth services and over-the-counter drugs, but it did not provide direct funding. The idea of direct funding has gained traction among some Republicans as a way to make HSAs more equitable, but it has not been adopted in any enacted legislation. The 118th Congress (2023-2024) saw several HSA-related bills, including the HSA Expansion Act and the Bipartisan HSA Improvement Act, but none included direct government funding. The closest was the 'Personal Health Investment Act' introduced by Rep. Blake Moore (R-UT) in 2023, which would have allowed individuals to receive a federal match for HSA contributions, but it did not advance. No FSA funding bills have been introduced in recent years, as FSAs are less popular and have a more complicated structure. The historical pattern suggests that direct funding is a politically difficult proposal that has not yet gained enough support to move through Congress.